Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 5 (2008), Issue 5 (May)

1. Lessons from the skin--cutaneous features of familial cancer.
   Lancet Oncol, 9(5): 462-72. [Abstract] [Full-text]
2. Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.
   Cancer Res, 68(9): 3467-75. [Abstract] [Full-text]
3. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.
   Cancer Res, 68(9): 3458-66. [Abstract] [Full-text]
4. Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroids.
   Cancer Res, 68(9): 3334-41. [Abstract] [Full-text]
5. How dysregulated colonic crypt dynamics cause stem cell overpopulation and initiate colon cancer.
   Cancer Res, 68(9): 3304-13. [Abstract] [Full-text]
6. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
   Cancer Res, 68(9): 3152-60. [Abstract] [Full-text]
7. APC mutation spectrum in ileoanal pouch polyps resembles that of colorectal polyps.
   Br J Surg, 95(6): 765-9. [Abstract] [Full-text]
8. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
   J Clin Oncol, 26(14): 2336-41. [Abstract] [Full-text]
9. Involvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells.
   Biochem Biophys Res Commun, 371(1): 172-6. [Abstract] [Full-text]
10. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
    Gastroenterology, 134(5): 1570-95. [Abstract] [Full-text]
11. Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells.
    Biochem Pharmacol, 75(11): 2122-34. [Abstract] [Full-text]
12. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice.
    Cancer Res, 68(10): 3985-91. [Abstract] [Full-text]
13. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
    Cancer Res, 68(10): 3707-14. [Abstract] [Full-text]
14. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia.
    Cancer Res, 68(10): 3573-8. [Abstract] [Full-text]
15. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
    BMC Biotechnol, 8: 46. [Abstract] [Full-text]
16. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    J Clin Oncol, 26(15): 2532-7. [Abstract] [Full-text]
17. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice.
    Radiology, 247(3): 779-87. [Abstract] [Full-text]
18. Colonic crypt organization and tumorigenesis.
    Nat Rev Cancer, 8(6): 415-24. [Abstract] [Full-text]
19. Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report.
    World J Surg Oncol, 6: 49. [Abstract] [Full-text]
20. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
    Lancet Oncol, 9(6): 596-9. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.